Japan, Jan. 16 -- DENKA CO LTD has got intellectual property rights for 'EPITOPE OF ANTIBODY AGAINST STRUCTURAL PROTEIN OF SARS-COV-2, ANTIBODY REACTING WITH EPITOPE, METHOD FOR DETECTING SARS-COV-2 USING ANTIBODY, DETECTION KIT FOR SARS-COV-2 CONTAINING ANTIBODY, METHOD FOR DETECTING ANTI-SARS-COV-2 ANTIBODY CONTAINING POLYPEPTIDE OF EPITOPE, DETECTION KIT FOR ANTI-SARS-COV-2 ANTIBODY CONTAINING POLYPEPTIDE OF EPITOPE, VACCINE FOR SARS-COV-2 CONTAINING POLYPEPTIDE OF EPITOPE, AND THERAPEUTIC AGENT FOR SARS-COV-2 INFECTION CONTAINING ANTIBODY.' Other related details are as follows:

Application Number: JP,2024-109831

Category (FI): A61K39/215,A61K39/395@S,A61P31/14,A61P37/04,C07K14/165,C07K16/10,C07K7/08,C12N15/13,G01N33/53@N,G01N33/569@L

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 8, 2024

Publication Date: Oct. 23, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.